Section Arrow
STIM.NASDAQ
- Neuronetics
Quotes are at least 15-min delayed:2025/08/25 18:36 EDT
After Hours
Last
 3.26
+0.06 (+1.88%)
Bid
3.2
Ask
3.3
High 3.26 
Low 3.2 
Volume 7352 
Regular Hours
Last
 3.2
-0.2 (-5.88%)
Day High 
3.38 
Prev. Close
3.4 
1-M High
4.8495 
Volume 
1.55M 
Bid
3.2
Ask
3.3
Day Low
3.175 
Open
3.38 
1-M Low
3.2 
Market Cap 
224.82M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.56 
20-SMA 3.97 
50-SMA 3.79 
52-W High 5.92 
52-W Low 0.52 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.15/-0.41
Enterprise Value
302.66M
Balance Sheet
Book Value Per Share
0.41
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
74.89M
Operating Revenue Per Share
1.05
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.4899-0.0101-2.02%-- 
After Hours 0.6202 +0.1303 +26.60%
DXCMDexCom75.96-6.3-7.66%57.93PE
After Hours 76.4 +0.44 +0.58%
MDTMedtronic plc92.04-0.67-0.72%25.68PE
After Hours 92.7 +0.66 +0.72%
BFLYButterfly Network1.55+0.03+1.97%-- 
After Hours 1.6 +0.05 +3.23%
ABTAbbott Laboratories131.87-0.72-0.54%16.64PE
After Hours 132.13 +0.26 +0.20%
Quotes are at least 15-min delayed:2025/08/25 18:36 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.